Easton, PA, United States of America

Charles Romfo

USPTO Granted Patents = 8 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Charles Romfo

Introduction

Charles Romfo is a notable inventor based in Easton, Pennsylvania. He has made significant contributions to the fields of gene expression and muscular dystrophy treatment. With a total of eight patents to his name, Romfo's work has the potential to impact medical research and therapeutic development.

Latest Patents

Romfo's latest patents include innovative methods and agents for screening compounds capable of modulating gene expression. This invention focuses on screening assays and compounds that can alter gene expression and protein levels. Additionally, he has developed methods for screening compounds aimed at treating muscular dystrophy by regulating human ALPHA7 integrin mRNA translation. These patents highlight his commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Romfo is currently associated with PTC Therapeutics, Inc., where he continues to work on groundbreaking research. His career is marked by a dedication to understanding and manipulating gene expression, which is crucial for developing new therapies.

Collaborations

Throughout his career, Romfo has collaborated with esteemed colleagues such as Nikolai A. Naryshkin and Ellen Welch. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Charles Romfo's contributions to the fields of gene expression and muscular dystrophy treatment exemplify the impact of dedicated inventors in the medical research landscape. His patents and ongoing work at PTC Therapeutics, Inc. continue to pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…